# Hematology Consultation

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Annie Oakley (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI021-SYN-TD
- Date: 1925-02-17
- Fictional facility: St. Posthumous Health Center
- Fictional author: Omar Salib, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Requested by: Ruth Ellingsen, MD

## Reason for consultation

Macrocytic anemia with mild leukopenia and thrombocytopenia in a woman of 64, with very low B12, raised MMA, and positive intrinsic factor antibodies. Please confirm pernicious anemia and advise on replacement, monitoring, and gastric risk. **S**

## History

Mrs. Oakley is seen at the request of Dr. Ellingsen one week after starting intramuscular cyanocobalamin for macrocytic anemia with low B12 and positive intrinsic factor antibodies. She has had all seven daily injections. Her tongue is less sore and her energy slightly better; the foot tingling and unsteadiness in the dark are unchanged. She has no bleeding, bruising, fevers, weight loss, or night sweats. No alcohol excess, nitrous oxide exposure, metformin, or acid suppressants. She teaches shooting classes and wants to keep doing so. **S**

## Examination

| System | Finding |
|---|---|
| General | Slight, pale, alert |
| Mouth | Smooth, red tongue, less inflamed |
| Lymph nodes and spleen | No lymph node enlargement; spleen not palpable |
| Neurological | Vibration absent at the toes and reduced at the ankles; proprioception reduced at the toes; Romberg positive; cognition normal |

BP 116/66 mmHg; pulse 90 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 46.4 kg; BMI 20.1 kg/m². All vital signs are synthetic.

## Data reviewed

The presenting blood count, reticulocytes, B12, folate, MMA, intrinsic factor antibody, LDH, bilirubin, iron studies, TSH, and kidney function; today's blood count, reticulocyte count of 6.8 percent, and potassium of 3.7 mmol/L. Hemoglobin: 9.6 g/dL (low); MCV: 110 fL (high); White cell count: 4.4 10*3/uL; Platelets: 196 10*3/uL; Reticulocytes: 6.8% (high); Potassium: 3.7 mmol/L. All results are synthetic.

## Assessment

1. **Pernicious anemia with B12 deficiency neuropathy** (D51.0). Established. Very low B12 with raised MMA confirms deficiency, and intrinsic factor antibodies are highly specific for pernicious anemia. The mild leukopenia and thrombocytopenia, raised LDH, and raised bilirubin come from ineffective red cell production in the marrow. The reticulocyte rise to 6.8 percent at one week, with counts already climbing, confirms the diagnosis. A bone marrow examination is not needed unless the counts fail to normalize by eight weeks. The neurologic signs show dorsal column involvement, so treatment must be by injection and must not lapse. **S**
2. **Autoimmune gastritis and gastric risk**. Pernicious anemia is the late stage of autoimmune gastritis, which raises the risk of type 1 gastric neuroendocrine tumors and gastric adenocarcinoma. She has never had an endoscopy. **S**
3. **Associated conditions**. Autoimmune thyroid disease is common with autoimmune gastritis; her TSH is normal. Iron deficiency often appears as red cell production recovers, because absorption of dietary iron is reduced without gastric acid. **S**

## Recommendations

1. Continue cyanocobalamin 1000 micrograms intramuscularly: weekly for four weeks after the daily week, then monthly for life. Oral B12 is not advised for her while neurologic signs are present, and injections should never be stopped.
2. If neurologic signs stop improving or symptoms return before each monthly dose, shorten the interval.
3. Blood count with MCV and MMA at eight weeks; do not repeat the B12 level.
4. Ferritin and transferrin saturation at eight weeks; if iron deficiency appears, treat it and complete the GI evaluation.
5. Upper endoscopy with biopsies of the gastric body and antrum in separate jars, of any polyp or nodule, and of the duodenum, with H. pylori testing. Surveillance after that by the findings: about every three years for advanced atrophy, every one to two years if neuroendocrine tumors are found.
6. TSH once a year.
7. Avoid nitrous oxide anesthesia, which inactivates B12.

## Strengths and supports

- Supports: a close family nearby and her students at the shooting club **S**

## Communication

Discussed with Dr. Ellingsen today; the patient agrees and has the plan in writing. **S**

## Follow-up

Hematology will see her again if the blood counts do not normalize by eight weeks or if new cytopenias appear. Primary care continues the injections and monitoring on the CMID schedule. **S**

## Guideline basis

- Vitamin B12 Deficiency: Recognition and Management. Am Fam Physician 2017;96(6):384-389 (2017), American Academy of Family Physicians
- Guidelines for the diagnosis and treatment of cobalamin and folate disorders (2014), British Society for Haematology
- AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review (2021), American Gastroenterological Association
- CMID: Clinical Monitoring Intelligence Database, anemia monograph (2026), Aether Forge
